Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Identification of cancer driver mutations is critical for advancing cancer research and personalized medicine. Due to inter-tumor genetic heterogeneity, many driver mutations occur at low frequencies, which make it challenging to distinguish them from passenger mutations. Here, we show that a novel...
Main Authors: | Zixing Wang, Kwok-Shing Ng, Tenghui Chen, Tae-Beom Kim, Fang Wang, Kenna Shaw, Kenneth L Scott, Funda Meric-Bernstam, Gordon B Mills, Ken Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0196939 |
Similar Items
-
CanDrA: cancer-specific driver missense mutation annotation with optimized features.
by: Yong Mao, et al.
Published: (2013-01-01) -
Whole Genome Sequencing in Cancer Clinics
by: Ken Chen, et al.
Published: (2015-01-01) -
Comprehensive assessment of computational algorithms in predicting cancer driver mutations
by: Hu Chen, et al.
Published: (2020-02-01) -
IntOMICS: A Bayesian Framework for Reconstructing Regulatory Networks Using Multi-Omics Data
by: Pačínková, A., et al.
Published: (2023) -
Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in Glioblastoma
by: Yang Yuan, et al.
Published: (2020-11-01)